Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11783258 | PMC |
| http://dx.doi.org/10.5114/aic.2024.144970 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The CONDUCT-AF trial: Rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillation.
Eur J Heart Fail
September 2025
Cardiology Department, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Aims: There is a lack of data from randomized clinical trials comparing treatment outcomes between conduction system pacing (CSP) modalities and biventricular pacing (BVP) in symptomatic patients with refractory atrial fibrillation (AF) scheduled for atrioventricular node ablation (AVNA). The CONDUCT-AF investigates whether CSP is non-inferior to BVP in improving left ventricular ejection fraction (LVEF) and clinical outcomes in heart failure (HF) patients with symptomatic AF undergoing AVNA.
Methods: This study is an investigator-initiated, prospective, randomized, multicentre clinical trial conducted across 10 European centres, enrolling 82 patients with symptomatic AF, HF with reduced LVEF, and narrow QRS.
Risk factors for coronary in-stent restenosis in Moroccan patients: a retrospective case-control study.
Cell Mol Biol (Noisy-le-grand)
September 2025
Medical School, Laboratory of Genetics and Molecular Pathology, University Hassan II, Casablanca, Morocco.
In-stent restenosis remains a significant challenge in interventional cardiology despite technological advancements. This retrospective case-control study conducted at the University Hospital Center Ibn Rochd in Casablanca (2020-2023) examined risk factors associated with coronary in-stent restenosis in 68 patients equally distributed between restenosis and no-restenosis groups. Diabetes emerged as a powerful predictor of restenosis (RR=4.
View Article and Find Full Text PDFCardiology in Poland: A report for the year 2024 - part 1.
Kardiol Pol
September 2025
Clinical Department of Cardiology, Centre of Heart Diseases, 4th Military Hospital, Wrocław, Poland.
Cardiology in Poland: A report for the year 2024 - part 2: Electrophysiology and device therapy.
Kardiol Pol
September 2025
Clinical Department of Cardiology, Centre of Heart Diseases, 4th Military Hospital, Wrocław, Poland.
Methodological rigor in AI-based angiographic analysis: A commentary on "Comparative evaluation of a convolutional neural network and interventional cardiologists in the diagnosis of significant stenosis of coronary arteries".
Kardiol Pol
September 2025
Clinical Department of Cardiology and Cardiovascular Interventions, University Hospital, Kraków, Poland.